Concordance analysis of IHC and FISH in the detection of ROS1 gene rearrangement in NSCLC: Results of a meta-analysis

被引：0
|
作者：
Godre, N. [1 ]
Gupta, V. [1 ]
Alam, M. [2 ]
机构：
[1] Pfizer India, Med Affairs Oncol, Mumbai, Maharashtra, India
[2] Pfizer Innovat Hlth, Med Affairs Oncol, Sydney, NSW, Australia
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
458P
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Detection of ROS1 Gene Rearrangement in Lung Adenocarcinoma: Comparison of IHC, FISH and Real-Time RT-PCR
    Shan, Ling
    Lian, Fang
    Guo, Lei
    Qiu, Tian
    Ling, Yun
    Ying, Jianming
    Lin, Dongmei
    PLOS ONE, 2015, 10 (03):
  • [2] A meta-analysis on epidemiology of ROS1 rearrangement in Asian and non-Asian population
    Gupta, V.
    Godre, N.
    Alam, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [3] Retrospective analysis of outcomes in UK patients with advanced NSCLC and ROS1 rearrangement
    Tokaca, N.
    Pouptsis, A.
    Karapanagiotou, E.
    Spicer, J.
    Halkyard, E.
    Blackhall, F.
    Summers, Y.
    Greystoke, A.
    Bhosle, J.
    Jones, A.
    Newsom-Davis, T.
    Nicolson, M.
    O'Brien, M.
    Yousaf, N.
    Popat, S.
    LUNG CANCER, 2018, 115 : S44 - S45
  • [4] Analysis of ROS1 gene rearrangement incidence among NSCLC patients with fluorescent in situ hybridization technique
    Wojas-Krawczyk, Kamila
    Jasielski, Patryk
    Krawczyk, Pawel
    Jankowski, Tomasz
    Wojcik-Superezynska, Magdalena
    Reszka, Katarzyna
    Chmielewska, Izabela
    Buczkowski, Jaroslaw
    Kucharczyk, Tomasz
    Szumilo, Justyna
    Kolb-Sielecki, Jaroslaw
    Sleiman, Youssef
    Szczesna, Aleksandra
    Ciszewski, Tomasz
    Ramlau, Rodryg
    Jagiello, Grazyna
    Krudys, Piotr
    Milanowski, Janusz
    ONCOLOGY IN CLINICAL PRACTICE, 2020, 16 (05): : 270 - 275
  • [5] ROS1 gene rearrangement and clinicopathological characteristics in Chinese NSCLC patients
    Ke, Wenbo
    Xu, Zhigao
    Xue, Liquan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (05): : 5594 - 5599
  • [6] Clinical characteristics of patients with ROS1 gene rearrangement in non-small cell lung cancer: a meta-analysis
    Bi, Huanhuan
    Ren, Dunqiang
    Ding, Xiaoqian
    Yin, Xiaojiao
    Cui, Shichao
    Guo, Caihong
    Wang, Hongmei
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (07) : 4383 - +
  • [7] Detection of ROS1 Rearrangement Using Immunohistochemistry: Correlation With ROS1 Fusion Analysis by Fluorescence In Situ Hybridization
    Coffman, Brittany
    Hettinga, Ana
    Buehler, Karen
    Vasef, Mohammad
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2018, 150 : S26 - S27
  • [8] A study detection of the ROS1 gene fusion by FISH and ROS1 protein expression by IHC methods in patients with ovarian malignant or borderline serous tumors
    Aydin, Hulya Ayik
    Pestereli, Elif
    Ozcan, Mualla
    Bayramoglu, Zeynep
    Erdogan, Gulgun
    Simsek, Tayup
    PATHOLOGY RESEARCH AND PRACTICE, 2018, 214 (11) : 1868 - 1872
  • [9] Comparative Evaluation of IHC versus FISH for Detection of ROS1 Fusion in Lung Cancer
    Kumar, R.
    Thulasidharan, N.
    Yadav, S.
    Pai, T.
    Joshi, A.
    Prabhash, K.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S448 - S448
  • [10] Correlation of ROS1 (D4D6) Immunohistochemistry with ROS1 FISH Analysis in Lung Adenocarcinoma: Is IHC a Reliable Screening Tool?
    Sharma, S.
    Dewan, A.
    Kini, L.
    Bhardwaj, M.
    Kumar, S.
    Sharma, D.
    Yadav, B.
    Pandey, R.
    Gogai, K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S999 - S999
12345